Senate Bill S1618

2025-2026 Legislative Session

Enacts the "New York affordable drug manufacturing act"

download bill text pdf

Sponsored By

Current Bill Status - In Senate Committee Health Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

2025-S1618 (ACTIVE) - Details

Current Committee:
Senate Health
Law Section:
Public Health Law
Laws Affected:
Add Art 2-A Title IV §§282 - 285, Pub Health L
Versions Introduced in Other Legislative Sessions:
2019-2020: S9020
2021-2022: S3048
2023-2024: S4786

2025-S1618 (ACTIVE) - Summary

Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.

2025-S1618 (ACTIVE) - Sponsor Memo

2025-S1618 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   1618
 
                        2025-2026 Regular Sessions
 
                             I N  S E N A T E
 
                             January 13, 2025
                                ___________
 
 Introduced by Sens. RIVERA, COONEY, MAY -- read twice and ordered print-
   ed, and when printed to be committed to the Committee on Health
 
 AN  ACT to amend the public health law, in relation to enacting the "New
   York affordable drug manufacturing act"
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Short  title. This act shall be known and may be cited as
 the "New York affordable drug manufacturing act".
   § 2. Article 2-A of the public health law is amended by adding  a  new
 title IV to read as follows:
                                 TITLE IV
                NEW YORK AFFORDABLE DRUG MANUFACTURING ACT
 SECTION 282. DEFINITIONS.
         283. PARTNERSHIPS;   PRODUCTION   AND  DISTRIBUTION  OF  GENERIC
                PRESCRIPTION DRUGS.
         284. REPORTING.
         285. PROPRIETARY INFORMATION.
   § 282. DEFINITIONS. AS USED IN THIS TITLE, THE FOLLOWING  TERMS  SHALL
 HAVE THE FOLLOWING MEANINGS:
   1.  "GENERIC PRESCRIPTION DRUG" MEANS A DRUG THAT IS APPROVED PURSUANT
 TO AN APPLICATION SUBMITTED UNDER SUBDIVISION (J) OF SECTION 355 OF  THE
 FEDERAL FOOD, DRUG, AND COSMETIC ACT (21 U.S.C.  SEC. 301 ET SEQ.), OR A
 BIOSIMILAR,  AS  DEFINED UNDER THE FEDERAL PUBLIC HEALTH SERVICE ACT (42
 U.S.C. SEC. 262) THAT IS NOT UNDER PATENT.
   2. "PARTNERSHIPS" MEANS AGREEMENTS  FOR  THE  PROCUREMENT  OF  GENERIC
 PRESCRIPTION  DRUGS  BY WAY OF CONTRACTS OR PURCHASING BY A PAYER, STATE
 GOVERNMENTAL AGENCY, GROUP PURCHASING ORGANIZATION, NONPROFIT  ORGANIZA-
 TION, OR OTHER ENTITY.
   §   283.   PARTNERSHIPS;   PRODUCTION   AND  DISTRIBUTION  OF  GENERIC
 PRESCRIPTION DRUGS. 1. (A) THE COMMISSIONER SHALL  ENTER  INTO  PARTNER-
 SHIPS, CONSISTENT WITH PARAGRAPH (B) OF SUBDIVISION TWO OF THIS SECTION,
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD04133-01-5
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.